202 related articles for article (PubMed ID: 25529795)
1. p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma.
Lehman HL; Yang X; Welsh PA; Stairs DB
Am J Pathol; 2015 Jan; 185(1):240-51. PubMed ID: 25529795
[TBL] [Abstract][Full Text] [Related]
2. Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma.
Chen T; Wang C; Wu F; Zhang X; Yang H; Deng X; He Q; Li W; Li G
PLoS One; 2015; 10(3):e0118645. PubMed ID: 25785604
[TBL] [Abstract][Full Text] [Related]
3. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes.
Lehman HL; Kidacki M; Stairs DB
Sci Rep; 2020 Nov; 10(1):18829. PubMed ID: 33139779
[TBL] [Abstract][Full Text] [Related]
4. Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma.
Chung Y; Lam AK; Luk JM; Law S; Chan KW; Lee PY; Wong J
Ann Surg Oncol; 2007 Nov; 14(11):3260-7. PubMed ID: 17647062
[TBL] [Abstract][Full Text] [Related]
5. NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation.
Lehman HL; Kidacki M; Warrick JI; Stairs DB
Oncotarget; 2018 Feb; 9(13):11180-11196. PubMed ID: 29541406
[TBL] [Abstract][Full Text] [Related]
6. Loss of p120ctn causes EGFR-targeted therapy resistance and failure.
Landmesser ME; Raup-Konsavage WM; Lehman HL; Stairs DB
PLoS One; 2020; 15(10):e0241299. PubMed ID: 33112928
[TBL] [Abstract][Full Text] [Related]
7. p120-Catenin Downregulation and
Kidacki M; Lehman HL; Green MV; Warrick JI; Stairs DB
Mol Cancer Res; 2017 Oct; 15(10):1398-1409. PubMed ID: 28637905
[TBL] [Abstract][Full Text] [Related]
8. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
9. Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.
Zhang G; Zhang Q; Zhang Q; Yin L; Li S; Cheng K; Zhang Y; Xu H; Wu W
J Cancer Res Clin Oncol; 2010 Apr; 136(4):587-94. PubMed ID: 19823871
[TBL] [Abstract][Full Text] [Related]
10. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
[TBL] [Abstract][Full Text] [Related]
11. PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma.
Pan BQ; Xie ZH; Hao JJ; Zhang Y; Xu X; Cai Y; Wang MR
Biochem Biophys Res Commun; 2020 Jan; 522(1):53-60. PubMed ID: 31735331
[TBL] [Abstract][Full Text] [Related]
12. The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.
Zhang JY; Bai CY; Bai YQ; Zhang JY; Wu ZY; Wang SH; Xu XE; Wu JY; Zhu Y; Rui Y; Li EM; Xu LY
Hum Pathol; 2014 Oct; 45(10):2014-22. PubMed ID: 25090917
[TBL] [Abstract][Full Text] [Related]
13. The Rho GTPase RhoE exerts tumor-suppressing effects in human esophageal squamous cell carcinoma via negatively regulating epidermal growth factor receptor.
Wang H; Wang Y; Liang B; He F; Li Y; Che J; Li X; Zhao H; Shi G
J Cancer Res Ther; 2016 Oct; 12(Supplement):60-63. PubMed ID: 27721256
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
Song Y; Li J; Zhu Y; Dai Y; Zeng T; Liu L; Li J; Wang H; Qin Y; Zeng M; Guan XY; Li Y
Oncotarget; 2014 Nov; 5(22):11669-80. PubMed ID: 25375090
[TBL] [Abstract][Full Text] [Related]
15. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.
Moghbeli M; Abbaszadegan MR; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Forghanifard MM
Med Oncol; 2013 Jun; 30(2):516. PubMed ID: 23456637
[TBL] [Abstract][Full Text] [Related]
16. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
17. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
18. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
19. A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.
Grugan KD; Vega ME; Wong GS; Diehl JA; Bass AJ; Wong KK; Nakagawa H; Rustgi AK
Cancer Biol Ther; 2013 Sep; 14(9):853-9. PubMed ID: 23792586
[TBL] [Abstract][Full Text] [Related]
20. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
